It appears the FDA aren't convinced it works. The only published RCT says it doesn't. I think I see the problem.
' Remestemcel-L did not meet the primary endpoint of greater DCR in the intent-to-treat population (35% versus 30%; P = 0.42).'
Whats all the whining about?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.110(4.82%) |
Mkt cap ! $3.078B | |||
| Open | High | Low | Value | Volume |
| $2.31 | $2.43 | $2.30 | $11.15M | 4.714M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 66509 | $2.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.40 | 47069 | 22 |
View Market Depth
| Last trade - 14.07pm 23/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |